I guess it's not true that they saved the best for last because I'm definitely not the best
Conclusion The weight loss gap between retatrutide and semaglutide is real, mechanistically explained, and consistent across two Phase 3 trials
COAs are matched to the exact lot shipped and held on the Lab Tests page for transparency and traceability
The Importance of Bioavailability Taking a supplement is only half the battle
Consistency is crucial for optimal results
Unlike older weight loss drugs that target a single hormone pathway, retatrutide activates three separate receptors: GLP-1 (glucagon like peptide 1), which slows digestion and reduces appetite GIP (glucose dependent insulinotropic polypeptide), which helps regulate blood sugar and insulin release Glucagon, which increases energy expenditure and supports fat burning By working on all three pathways together, retatrutide aims to produce a stronger combined effect than medicines that only target one or two of these hormones, such as semaglutide or tirzepatide
